World COVID-19 January 28: UK and EU highly recommend booster dose

World COVID-19 January 28: UK and EU highly recommend booster dose - Photo 1.

British Prime Minister Boris Johnson (left) inspects the booster dose campaign at the vaccination center in Buckinghamshire, UK – Photo: REUTERS

UKHSA says that for about six months after a second dose of any COVID-19 vaccine, protection against the risk of death from the Omicron variant is about 60 per cent in people aged 50 and over. However, this number increased to about 95% in the two weeks following the booster dose.

UKHSA adds that the booster dose also helps reduce hospital admissions from COVID-19. The effectiveness of preventing hospitalization is approximately 90% for the Pfizer-BioNTech injection, decreasing to 75% in 10-14 weeks after the booster dose.

For the Moderna shot, the effectiveness in preventing hospitalization was 90-95% for up to 9 weeks after the booster shot.

“There is strong evidence that vaccines protect all of us against the effects of COVID-19 and booster doses increase protection against hospitalization and death in the most vulnerable people in society. our society,” said Dr Mary Ramsay from UKHSA.

UKHSA also released an initial analysis of the vaccine’s effectiveness against sub-variants of Omicron BA.1 and BA.2 – strains that are widespread in the UK and Denmark.

“After two doses, the efficacy was 9% and 13% for BA.1 and BA.2, respectively, over 25 weeks,” UKHSA said. “This increased to 63% for BA.1 and 70% for BA.2 from two weeks after the booster dose.”

The ECDC is of the same opinion as UKHSA, which says a booster dose could reduce future COVID-19 hospitalizations by up to 800,000 in Europe.

“Implementing a booster injection in early January could reduce future hospitalizations by at least half a million people,” the ECDC said.

According to Reuters news agency, about 70% of the EU’s 450 million people have received two doses of the vaccine and half of the population have received a booster dose.

Leave a Comment